Can I get Mounjaro with a BMI of 25?

Picture the scenario: a BMI of 25 and a question nobody seems to answer directly

You've done the calculation, typed in your height and weight, and come out at 25. Maybe you've read about Mounjaro, seen the clinical trial results, and wondered whether the medicine could work for you. The question you're really asking is whether there's any pathway to treatment at this BMI, and the honest answer is: not through a licensed UK prescriber.

Tirzepatide (the active ingredient in Mounjaro) was studied in adults with obesity or overweight plus weight-related health conditions. The MHRA granted its UK licence on that evidence base. A prescribing threshold of BMI 30 (or 27 with comorbidities) isn't an arbitrary number; it reflects the population in whom the medicine has been assessed for benefit and risk. The BMI requirements for Mounjaro are set by the medicine's SmPC, and a GPhC-registered prescriber is bound by those terms. Prescribing outside a licence boundary without compelling clinical justification would put the prescriber in breach of their professional duties. No reputable clinic will do it.

A BMI of 25 also sits in what the NHS classifies as the 'healthy weight' range. That doesn't mean everyone at this BMI feels well or is free from metabolic health concerns, it means the population-level evidence for a medicine of this type, at this risk-benefit profile, does not extend to this BMI band. The NHS BMI calculator puts that reading into context if you want to check what band applies to your measurements.

What 'BMI of 27 with a condition' actually means in practice

The lower of the two licensed thresholds (BMI of 27 with at least one weight-related condition) is where things get slightly more nuanced. Conditions that count in this context include type 2 diabetes, prediabetes, hypertension, dyslipidaemia (raised cholesterol or triglycerides), obstructive sleep apnoea, and osteoarthritis, among others. A prescriber assesses the whole clinical picture, not just the BMI figure on a form.

Even so, a BMI of 25 does not reach that lower threshold of 27. The ethnic-background adjustment worth knowing about (where UK guidance recognises a 2.5 kg/m² lower cut-off for South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds) would bring the lower threshold down to approximately 24.5 with a qualifying condition. At a BMI of exactly 25, that adjustment could theoretically be relevant, but it is borderline and still requires both the ethnic-background consideration and a confirmed weight-related health condition. This is precisely the kind of nuanced question that belongs in a proper clinical assessment, not a calculator. How BMI eligibility for Mounjaro actually works goes into this in more detail.

If your BMI is genuinely at 25 with no qualifying conditions, a prescriber will not be able to approve tirzepatide. That is not a decision made to be unhelpful, it is the medicine operating within its licensed boundaries, which is what keeps it safe.

What to do if your BMI is close to the threshold

If you are sitting at 25 and wondering whether your circumstances might one day meet the criteria, a few things are worth considering. First, BMI measurements vary, scales, time of day, and method matter. A formal clinical assessment takes weight and height readings carefully. Second, if you have a weight-related health condition that hasn't been formally diagnosed, a GP appointment to explore that is a reasonable step before approaching any weight-management service. Third, the licensed threshold is a minimum, not a guarantee, a prescriber still assesses the full picture, including other medicines you take, your health history, and your goals.

For people whose BMI sits at 27 or above, understanding who can get Mounjaro through a private clinic lays out what the process actually involves. And if your BMI is closer to 28, the considerations are slightly different, the picture at BMI 28 explains where that sits within the licensed criteria.

num's prescribers review every consultation personally on the same day, a named clinician, not automated software, reads your answers. If it becomes clear during that review that a BMI of 25 doesn't meet the licensed threshold, they will tell you plainly rather than approve something that isn't clinically appropriate. That matters more than a fast yes. You can find more about Mounjaro as a treatment and what the evidence shows on our main Mounjaro page. If cost context is something you are researching alongside eligibility, our weight-loss treatments page covers what's included in the consultation process.

What your options might look like at BMI 25

Mounjaro aside, a BMI of 25 with a genuine desire to manage weight or improve metabolic health is not a situation that leaves you without any recourse. Lifestyle change remains the best-evidenced first line, the NHS's healthy weight guidance covers practical diet and activity steps that have real support behind them. A GP conversation about your specific health concerns, blood markers, and risk factors is often the most useful starting point. Some people find that tracking their BMI over time, particularly if they have a qualifying condition, means their eligibility picture changes.

We're occasionally asked whether orlistat (a different type of weight-management medicine, a lipase inhibitor available in capsule form) has different eligibility requirements. It does, though it has a different mechanism, different side-effect profile, and different evidence base. The question of combining Mounjaro and orlistat is one our prescribers field from time to time; at a BMI of 25, Mounjaro isn't in scope for either question.

If your BMI is right on the boundary (say 26 or 27) and you have at least one relevant condition, a consultation is the only way to get a definitive answer tailored to your situation. A calculator on a website, including this one, cannot replace that.